Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3C.L Regulatory News (K3C)

  • There is currently no data for K3C

Trading Update

25 Mar 2020 07:00

RNS Number : 4675H
K3 Capital Group PLC
25 March 2020
 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

K3 CAPITAL GROUP PLC

("K3", the "Company" and including its subsidiaries, the "Group")

 

Trading update

 

K3 Capital Group plc, a leading business and company sales specialist in the UK, provides the following update in light of current equity market conditions and the rapidly changing developments regarding COVID-19.

 

The Company is pleased to report a positive trading period to the end of March 2020 with revenues for 10 months expected to reach a minimum of £14.3m +29% (corresponding 10 month period FY19 £11.1m), giving rise to an adjusted EBITDA of £6.5m +59% (corresponding 10 month period FY19 £4.1m). This shows a significant improvement compared with the same period FY19 with all three brands showing positive trends in both revenue and EBITDA. This represents the lowest expected outturn for the Group's performance over this 10 month financial period, with further scope for improvement subject to the completion of certain pipeline transactions in March.

Clearly the impact of COVID-19 on the UK SME market, from which the Group derives its business through the sale of such businesses, is significant. As a result, the Board fully expects a slowdown in revenues across the Group in the coming months and is closely monitoring the wider impact on operational KPIs.

In light of these difficult trading conditions and the Directors' prudent approach to the management of its overheads, the Company has reviewed its operational cost base and taken material, short term measures to mitigate the impact of COVID-19 on financial performance. This includes salary sacrifices across the plc Board and senior management team, together with general overhead reductions and the 'furloughing' of a proportion of the workforce under the Government's recently announced 'Job Retention Scheme'. As a result of these initiatives, the Group's monthly overheads are expected to reduce by approximately 70 per cent. from April 2020 and the Board therefore expects that the Company will be EBITDA positive in the months of April and May. The Company will also have the ability to extend these overhead savings beyond that period as required, subject to continued Government and management support.

It is important to note that all Directors, managers and senior people together with some support staff will continue to work within the business and that each and every department will be fully functional across each of the three brands to help our clients preparation in achieving their ultimate objectives.

The Company has taken the view to support the workforce as much as possible during this turbulent period and through a range of measures will look to minimise the number of job losses which may take place.

As a result of the many unknowns relating to COVID-19 in terms of timeline and both macro and micro economic consequences, the Board is unable to quantify the impact on the Group's financial and trading performance beyond the end of the current financial year and has therefore decided to suspend financial guidance going forward in future trading periods until both the impact and duration of the pandemic becomes clearer.

John Rigby (CEO) is highly experienced. He previously managed the rationalisation of the business during the global recession of 2009 and was subsequently responsible for managing its recovery and ongoing growth over the last 10 years.

 

John Rigby, CEO of K3, commented:

"Unlike 2009, the Company is in a very strong financial position with over £7m in bank reserves and no debt or gearing. Many of our competitors are not in such an enviable position and we expect this to create opportunities moving forward. In addition, we have a strong and experienced senior team combined with an automated business model which uses the latest data and technology therefore making us much more robust and opportunist to take advantage when the market shows signs of recovery. We are mindful that no one knows the severity of the current crisis but when there is light at the end of the tunnel business owners will no doubt be highly incentivised to capitalise on their business value and at the same time we believe that both trade and investment buyers both within the UK and overseas will be looking for opportunities and routes to expand through acquisition".

 

-ENDS-

 

For further information please contact:

K3 Capital Group plc

Tel: c/o finnCap 020 7220 0500

John Rigby, Chief Executive Officer

www.k3capitalgroupplc.com

Andrew Melbourne, Chief Financial Officer

 

 

 

finnCap Ltd (Nominated Adviser and Sole Broker)

Tel: 020 7220 0500

Jonny Franklin-Adams, Anthony Adams (Corporate Finance)

Tim Redfern, Richard Chambers (Corporate Broking)

 

 

 

 

About K3 Capital

K3 Capital Group plc is a leading business sales and brokerage firm headquartered in Bolton with operations throughout the UK. It acts for vendors of businesses from c. £50,000 to c. £200 million through its three trading subsidiaries Knightsbridge, KBS Corporate, and KBS Corporate Finance. K3, through its trading subsidiaries, has received a number of adviser awards, most recently achieving the number 1 position in the 2019 Refinitiv Mid-Market M&A Review.

 

K3 Capital operates a disruptive business model with a direct marketing approach to client acquisition, using incentivised and experienced salespeople rather than advisory teams, while its highly visible online presence and proprietary online business valuation portal generates further leads. This innovative model, combined with a continuing strategy towards targeting higher value clients, are key drivers for growth and profitability.

 

The Group also offers all clients fully contingent and inclusive legal fees through its partner relationships with local and national law firms.

 

K3 Capital Group trades on the London Stock Exchange (AIM: K3C.L), having listed on 11 April 2017. Please visit www.k3capitalgroupplc.com for more information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFFFLIVSISFII
Date   Source Headline
7th Sep 20207:00 amRNSInvestor Presentation
7th Aug 20202:36 pmRNSHolding(s) in Company
7th Aug 202011:26 amRNSHolding(s) in Company
3rd Aug 20207:00 amRNSAcquisition, Directorate Changes & Results Notice
21st Jul 20204:32 pmRNSHolding(s) in Company
21st Jul 20202:51 pmRNSHolding(s) in Company
20th Jul 20203:51 pmRNSHolding(s) in Company
20th Jul 20202:35 pmRNSHolding(s) in Company
17th Jul 202011:30 amRNSResult of General Meeting
2nd Jul 20205:40 pmRNSHolding(s) in Company
2nd Jul 20205:37 pmRNSHolding(s) in Company
1st Jul 20202:37 pmRNSHolding(s) in Company
1st Jul 202011:59 amRNSHolding(s) in Company
30th Jun 20202:00 pmRNSPosting of Circular and Notice of General Meeting
29th Jun 20202:05 pmRNSSecond Price Monitoring Extn
29th Jun 20202:00 pmRNSPrice Monitoring Extension
29th Jun 20201:25 pmRNSResult of Fundraising
29th Jun 20207:01 amRNSPrimaryBid.com Offers
29th Jun 20207:00 amRNSProposed Fundraising to Raise up to £30.5 million
7th Apr 20204:42 pmRNSSecond Price Monitoring Extn
7th Apr 20204:36 pmRNSPrice Monitoring Extension
6th Apr 20207:00 amRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSTrading Update
10th Mar 20202:00 pmRNSDirector/PDMR Shareholding
28th Feb 202011:00 amRNSPrice Monitoring Extension
19th Feb 20203:00 pmRNSDirector/PDMR Shareholding
5th Feb 20202:30 pmRNSDirector/PDMR Shareholding
4th Feb 20207:00 amRNSHalf-year Report
16th Dec 20197:00 amRNSTrading Update
20th Nov 20196:05 pmRNSHolding(s) in Company
18th Oct 20191:30 pmRNSResult of AGM
17th Sep 20191:43 pmRNSFinal Dividend Timetable
17th Sep 20197:00 amRNSNotice of AGM
17th Sep 20197:00 amRNSFinal Results
21st Aug 201910:25 amRNSHolding(s) in Company
17th Jun 201912:00 pmRNSCorrection: Director/PDMR Shareholding
14th Jun 20192:40 pmRNSDirector/PDMR Shareholding
6th Jun 20192:09 pmRNSDirector/PDMR Shareholding
5th Jun 20197:00 amRNSTrading Update and Notice of Results
16th May 20194:30 pmRNSHolding(s) in Company
8th Apr 201911:41 amRNSHolding(s) in Company
8th Apr 20197:00 amRNSDirector/PDMR Shareholding
5th Apr 20197:00 amRNSTrading Update
21st Jan 20197:00 amRNSHalf-year Report
12th Dec 20187:00 amRNSLeading Advisor in Mid-Market M&A Adviser Rankings
11th Dec 20187:00 amRNSTrading Update
6th Dec 20184:52 pmRNSHolding(s) in Company
11th Oct 201811:05 amRNSSecond Price Monitoring Extn
11th Oct 201811:00 amRNSPrice Monitoring Extension
26th Sep 20185:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.